Earnings Call to discuss the Audited Financial Results of the Company for the quarter and financial year ended March 31, 2026.
STAR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Strides Pharma Science has scheduled an earnings call for Monday, May 18, 2026 at 5:00 PM IST to discuss the company's audited financial results for Q4FY26 and the full financial year ended March 31, 2026. The conference call will feature the company's top leadership including Managing Director & Group CEO Badree Komandur and Group CFO Vikesh Kumar. The company has provided multiple dial-in numbers for participants from India, USA, Singapore, UK, and Hong Kong. This announcement follows regulatory requirements to inform investors about upcoming earnings discussions. The actual financial results have not been disclosed in this filing.
This announcement indicates Strides Pharma is on track to report its FY26 annual and Q4 results around May 18, 2026. The participation of both the CEO and CFO suggests this will be a comprehensive earnings discussion. Retail investors can dial in to hear management's commentary on Q4FY26 performance and full-year performance.